Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PCSK9 | Q8NBP7 | 20/20 | 0.65 |
| ▸ | RPLP1 | P05386 | 1/20 | 0.52 |
| ▸ | RPLP0 | P05388 | 1/20 | 0.52 |
| ▸ | RPS17 | P08708 | 1/20 | 0.52 |
| ▸ | RPSA | P08865 | 1/20 | 0.52 |
| ▸ | RPS2 | P15880 | 1/20 | 0.52 |
| ▸ | RPL35A | P18077 | 1/20 | 0.52 |
| ▸ | RPL7 | P18124 | 1/20 | 0.52 |
| ▸ | RPL17 | P18621 | 1/20 | 0.52 |
| ▸ | RPS4Y1 | P22090 | 1/20 | 0.52 |
| ▸ | RPS3 | P23396 | 1/20 | 0.52 |
| ▸ | RPS12 | P25398 | 1/20 | 0.52 |
| ▸ | RPL13 | P26373 | 1/20 | 0.52 |
| ▸ | RPL10 | P27635 | 1/20 | 0.52 |
| ▸ | RPL12 | P30050 | 1/20 | 0.52 |
| ▸ | RPL9; RPL9P7; RPL9P8; RPL9P9 | P32969 | 1/20 | 0.52 |
| ▸ | RPL22 | P35268 | 1/20 | 0.52 |
| ▸ | RPL4 | P36578 | 1/20 | 0.52 |
| ▸ | RPS19 | P39019 | 1/20 | 0.52 |
| ▸ | RPL3 | P39023 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17669178 | 0.96 | PCSK9 (0.59) | PCSK9RPLP1RPLP0RPS17RPSA | |
| SCHEMBL17679148 | 0.94 | PCSK9 (0.66) | PCSK9 | |
| SCHEMBL17679158 | 0.94 | PCSK9 (0.73) | PCSK9 | |
| SCHEMBL17679146 | 0.94 | PCSK9 (0.73) | PCSK9 | |
| SCHEMBL17669181 | 0.93 | PCSK9 (0.59) | PCSK9RPLP1RPLP0RPS17RPSA | |
| SCHEMBL17669182 | 0.93 | PCSK9 (0.59) | PCSK9RPLP1RPLP0RPS17RPSA | |
| SCHEMBL17669203 | 0.90 | PCSK9 (0.68) | PCSK9 | |
| SCHEMBL17669193 | 0.90 | PCSK9 (0.68) | PCSK9 | |
| SCHEMBL17669217 | 0.90 | PCSK9 (0.67) | PCSK9KCNH2 | |
| Pf-06815345 SCHEMBL17679156 | 0.88 | PCSK9 (0.62) | PCSK9KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016055901-A1 | SUBSTITUTED AMIDE COMPOUNDS | PFIZER INC. (US) | 2016-04-14 | — | — | WO | disclosed |
| US-20160102074-A1 | SUBSTITUTED AMIDE COMPOUNDS | PFIZER INC. (US) | 2016-04-14 | — | — | US | disclosed |
| US-20160102074-A1 | SUBSTITUTED AMIDE COMPOUNDS | PFIZER INC. (US) | 2016-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160102074-A1 | SUBSTITUTED AMIDE COMPOUNDS | CETP, APOB, LCAT | PCSK9 35/4885RPLP1 3305/4885RPLP0 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.